Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on May 31, 2025

Snail Inc. 旗下独立品牌 Wandering Wizard 与拉丁美洲工作室 Seven Leaf Clover 达成发行合作,加速全球市场布局
加利福尼亚州卡尔弗城, May 31, 2025 (GLOBE NEWSWIRE) -- 全球领先的互动数字娱乐领域独立开发商与发行商 Snail, Inc. (Nasdaq: SNAL,以下简称 “Snail Games” 或 “公司”) 宣布,其独立游戏发行品牌 Wandering Wizard 已与阿根廷开发商 Seven Leaf Clover 达成发行合作协议,获得高强度第一人称单人射击游戏 (FPS) Rebel Engine 的发行权。 Rebel Engine 预计将于 2025 年登陆 …

Snail Inc. 旗下獨立品牌 Wandering Wizard 與拉丁美洲工作室 Seven Leaf Clover 建立發行合作夥伴關係,擴大在全球市場的影響力
加利福尼亞州卡爾弗城, May 31, 2025 (GLOBE NEWSWIRE) -- 全球領先的互動數碼娛樂獨立開發商及發行商 Snail, Inc. (Nasdaq: SNAL)(「Snail Games」或「公司」)宣布其獨立發行品牌 Wandering Wizard,與來自阿根廷的開發商 Seven Leaf Clover 建立發行合作夥伴關係,以獲取極具影響力、單人第一人稱射擊(「FPS」)遊戲 《Rebel Engine》 的發行權利。 遊戲預計將於 2025 年在 PC …

La Corporation Trans Mountain annonce ses résultats financiers pour le premier trimestre de 2025
CALGARY, Alberta, 30 mai 2025 (GLOBE NEWSWIRE) -- la Corporation Trans Mountain (la « CTM » ou la « société ») a publié ses états financiers et le rapport de la direction qui s’y rattache pour le trimestre clos le 31 mars 2025. Les résultats financiers de …

Trans Mountain Corporation Releases First Quarter 2025 Financial Results
CALGARY, Alberta, May 30, 2025 (GLOBE NEWSWIRE) -- Trans Mountain Corporation (“TMC” or “the Company”) has released its financial statements and associated management report for the three months ending March 31, 2025. The Company’s financial results are …

New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreated LTC residents are often given a broader diagnosis of extrapyramidal syndrome, …

Teva Presents Latest Schizophrenia Portfolio Data Including Real-World Outcomes with UZEDY® (risperidone) Showing Lower Rates of and Longer Time to Relapse Compared to Oral Treatment Options and New Phase 3 SOLARIS Data Showing No Incidence of PDSS…
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED) visits versus second-generation daily oral options Latest Phase 3 SOLARIS data show no …

NEW WAVE ANNOUNCES Closing of Non-Brokered Private Placement of Units
VANCOUVER, BC, May 30, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (the “Company” or “New Wave”) (CSE: NWAI, FWB: 0XM0, OTCPK: TRMNF) announces, further to its news release of May 20 and May 29, 2025, that the Company has closed the previously …

Lancaster Resources Announces Closing Conditions Met for Lake Cargelligo Acquisition
VANCOUVER, British Columbia, May 30, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF0) (“Lancaster”), is pleased to announce it has received approval from the Canadian Securities Exchange to complete the acquisition of …